Complementary cyclisation reactions of hex-2-ene-1,6-diamine derivatives were exploited in the synthesis of alternative molecular scaffolds. The value of the synthetic approach was analysed using
Controlling molecular properties is crucial in drug discovery because the probability of successful progression is influenced by parameters including lipophilicity, molecular weight, the number of aromatic rings and the fraction of sp 3 -hybridised carbons (Fsp 3 ). 1 As a result, guidelines, such as Lipinski's ruleof-five (concerning oral bioavailability), 2 have been formulated to help chemists to target drug-relevant chemical space. 3 In turn, controlling the molecular properties of lead compounds is advisable since optimisation generally increases lipophilicity, molecular weight and complexity. 4 As a result, lead-like chemical space can be described in terms of both molecular properties (e.g. 5 À1 o c log P o 3; 14 r heavy atoms r 26) and structural features. 5 Unfortunately, most commercially-available compounds 5 (PMI) and mean deviation from the plane of best fit 14b of low-lying conformers are determined. To demonstrate LLAMA's utility, we analysed the lead-likeness of some scaffolds prepared using an approach that we have developed.
We envisaged a divergent synthetic approach in which unsymmetrical unsaturated diamine derivatives 1 would be converted Fig. 1 Graphical representation of the LLAMA workflow. A virtual library is enumerated by decoration of entered scaffolds once or twice using definable capping reagents and reactions. The lead-likeness, three-dimensionality and novelty of the virtual library may be analysed.
into alternative scaffolds (Scheme 1). Thus, complementary cyclisations would yield alternative heterocyclic intermediates 2; further cyclisation or rearrangement would then yield additional molecular scaffolds 3. The approach would be reminiscent of a branching pathway approach which enabled a single substrate to be converted into twelve natural product-like scaffolds. 15 The fate of the iodocyclisation reactions of hex-2-ene-diamine derivatives 1 was dependent on the specific protecting groups used (Scheme 2). Thus, treatment of the differentially-protected 1a with iodine and sodium bicarbonate in acetonitrile resulted in cyclisation of the remote Boc-protected amine to yield the pyrrolidine 4 in 76% yield. 16 In stark contrast, under the same conditions, the doubly Boc-protected amine 1b cyclised through the allylic carbamate to give a 95 : 5 mixture of the oxazinone 7 and the corresponding oxazolidinone (66% and 4% yield respectively). 17 In each case, regioselectivity was determined using the diagnostic upfield 13 C NMR chemical shift of the iodine-substituted carbons. Treatment of the trichloroacetamide 4 with LiHMDS induced cyclisation to yield the oxazoline 5 which could be hydrolysed to give the differentially-protected diamine 6. In contrast, treatment of the oxazinone 7 with LiHMDS triggered an unexpected rearrangement to give the isomeric oxazolidinone 8. Presumably, deprotonation of 7 results in participation to yield the corresponding aziridine 12 which is then ring-opened by iodide (Scheme 3). The trans configuration of the oxazolidinone 8 was assigned by the characteristic 18 Palladium-catalysed aminoarylation also enabled cyclisation onto the central alkene of 1b and the differentially-protected 1c. With 5 mol% Pd(OAc) 2 , 10 mol% BINAP, Cs 2 CO 3 in dioxane at 100 1C, 21 cyclisation occurred as expected exclusively through the distal nitrogen to afford the corresponding pyrrolidines 10a-b and 11a-b with B85 : 15 diastereoselectivity. A range of bicyclic scaffolds was prepared from the cyclisation products 6 and 10a (Scheme 4). Thus, Boc-deprotection of 6, and reaction with CDI, yielded the bicyclic oxazolidinone 13. Similarly, 10a was converted into the related bicyclic scaffold 16. Alternatively, capping of the hydroxyl group of 6 by silylation, followed by Boc deprotection and LiHMDS-mediated cyclisation yielded the alternative bicyclic scaffold 14. Finally, t BuOK in THF triggered cyclisation of the hydroxy group of 6 (with displacement of trichloromethyl anion) Scheme 3 Possible mechanism for the rearrangement of oxazin-2-one 7.
Scheme 4 Synthesis of bicyclic molecular scaffolds. Overall, six diverse scaffolds were therefore prepared from the differentially-protected diamines 1. LLAMA was used to assess the value of the scaffolds 17-22 (Fig. 3) . In each case, the enumerated library comprised compounds that had been decorated once or twice with exemplar medicinal chemistry capping groups. ¶ Our approach yielded scaffolds that allow significant lead-like chemical space to be explored [average lead-likeness penalty: 1.57 (s = 1.44) for our virtual library cf. 4.17 (s = 3.17) for compounds from the ZINC database] (Panel B). In addition, the enumerated compounds are significantly more three-dimensional than a random 2% of the ZINC database (Panels C and D). Finally, the novelty assessment showed that the Murcko assembly (without alpha-atoms) of only one scaffolds was known (18 with Ar 2 = 4-trifluoromethylphenyl) in the 2% selection of the ZINC database; however, the Murcko assembly with alpha atoms was not known for this scaffold, indicating that its substitution pattern is novel. We note that LLAMA may also be used prospectively to design scaffolds (e.g. specific Ar 2 groups in 19) that are both novel and lead-like.
In conclusion, our synthetic approach exploited complementary cyclisations of hex-2-ene-1,6-diamine derivatives to yield a range of novel, lead-like small molecule scaffolds. The computational tool LLAMA can support the development of lead-oriented synthetic approaches by enabling assessment of the lead-likeness of alternative product scaffolds.
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Notes and references ‡ The proportion has been estimated to 2.6% (ref. § LLAMA is available at: https://llama.leeds.ac.uk. ¶ The scaffolds 17-19 already contain a variable group (Ar 1 or Ar 2 ) and were subjected to only one further decoration.
